CDK9 and hepatocellular carcinoma: Pang et al. reported that miR-206 could inhibit the growth of hepatocellular carcinoma cells via targeting CDK9 [25], while another group demonstrated that miR-206 regulates the proliferation and metastasis of HCC cells via targeting E2F5 [26].